At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant data

Abstract Background Tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral ribonucleic acid (RNA) using reverse transcription polymerase chain reaction (RT-PCR) are pivotal to detecting current coronavirus disease (COVID-19) and duration of detectable virus indicating potential...

Full description

Bibliographic Details
Main Authors: Sue Mallett, A. Joy Allen, Sara Graziadio, Stuart A. Taylor, Naomi S. Sakai, Kile Green, Jana Suklan, Chris Hyde, Bethany Shinkins, Zhivko Zhelev, Jaime Peters, Philip J. Turner, Nia W. Roberts, Lavinia Ferrante di Ruffano, Robert Wolff, Penny Whiting, Amanda Winter, Gauraang Bhatnagar, Brian D. Nicholson, Steve Halligan
Format: Article
Language:English
Published: BMC 2020-11-01
Series:BMC Medicine
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12916-020-01810-8
id doaj-f3014ca9f7814ab8b99e56eedf96d184
record_format Article
spelling doaj-f3014ca9f7814ab8b99e56eedf96d1842020-11-25T04:05:57ZengBMCBMC Medicine1741-70152020-11-0118111710.1186/s12916-020-01810-8At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant dataSue Mallett0A. Joy Allen1Sara Graziadio2Stuart A. Taylor3Naomi S. Sakai4Kile Green5Jana Suklan6Chris Hyde7Bethany Shinkins8Zhivko Zhelev9Jaime Peters10Philip J. Turner11Nia W. Roberts12Lavinia Ferrante di Ruffano13Robert Wolff14Penny Whiting15Amanda Winter16Gauraang Bhatnagar17Brian D. Nicholson18Steve Halligan19Centre for Medical Imaging, University College LondonNIHR In Vitro Diagnostics Co-operative, Newcastle UniversityNIHR In Vitro Diagnostics Co-operative, Newcastle upon Tyne Hospitals NHS Foundation TrustCentre for Medical Imaging, University College LondonCentre for Medical Imaging, University College LondonNIHR In Vitro Diagnostics Co-operative, Newcastle UniversityNIHR In Vitro Diagnostics Co-operative, Newcastle UniversityExeter Test Group, Institute of Health Research, University of Exeter Medical School, University of ExeterTest Evaluation Group, Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of LeedsExeter Test Group, Institute of Health Research, University of Exeter Medical School, University of ExeterExeter Test Group, Institute of Health Research, University of Exeter Medical School, University of ExeterNuffield Department of Primary Care Health Sciences, University of OxfordCancer Services, Gastroenterology, Population Health & Primary Care, Bodleian Health Care Libraries, University of OxfordTest Evaluation Research Group, Institute of Applied Health Research, University of BirminghamKleijnen Systematic Reviews LtdBristol Medical School, University of BristolNIHR In Vitro Diagnostics Co-operative, Newcastle upon Tyne Hospitals NHS Foundation TrustFrimley Health NHS Foundation TrustNuffield Department of Primary Care Health Sciences, University of OxfordCentre for Medical Imaging, University College LondonAbstract Background Tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral ribonucleic acid (RNA) using reverse transcription polymerase chain reaction (RT-PCR) are pivotal to detecting current coronavirus disease (COVID-19) and duration of detectable virus indicating potential for infectivity. Methods We conducted an individual participant data (IPD) systematic review of longitudinal studies of RT-PCR test results in symptomatic SARS-CoV-2. We searched PubMed, LitCOVID, medRxiv, and COVID-19 Living Evidence databases. We assessed risk of bias using a QUADAS-2 adaptation. Outcomes were the percentage of positive test results by time and the duration of detectable virus, by anatomical sampling sites. Results Of 5078 studies screened, we included 32 studies with 1023 SARS-CoV-2 infected participants and 1619 test results, from − 6 to 66 days post-symptom onset and hospitalisation. The highest percentage virus detection was from nasopharyngeal sampling between 0 and 4 days post-symptom onset at 89% (95% confidence interval (CI) 83 to 93) dropping to 54% (95% CI 47 to 61) after 10 to 14 days. On average, duration of detectable virus was longer with lower respiratory tract (LRT) sampling than upper respiratory tract (URT). Duration of faecal and respiratory tract virus detection varied greatly within individual participants. In some participants, virus was still detectable at 46 days post-symptom onset. Conclusions RT-PCR misses detection of people with SARS-CoV-2 infection; early sampling minimises false negative diagnoses. Beyond 10 days post-symptom onset, lower RT or faecal testing may be preferred sampling sites. The included studies are open to substantial risk of bias, so the positivity rates are probably overestimated.http://link.springer.com/article/10.1186/s12916-020-01810-8SARS-CoV-2RT-PCRCOVID-19QUADAS-2Diagnostic testAnatomical sampling
collection DOAJ
language English
format Article
sources DOAJ
author Sue Mallett
A. Joy Allen
Sara Graziadio
Stuart A. Taylor
Naomi S. Sakai
Kile Green
Jana Suklan
Chris Hyde
Bethany Shinkins
Zhivko Zhelev
Jaime Peters
Philip J. Turner
Nia W. Roberts
Lavinia Ferrante di Ruffano
Robert Wolff
Penny Whiting
Amanda Winter
Gauraang Bhatnagar
Brian D. Nicholson
Steve Halligan
spellingShingle Sue Mallett
A. Joy Allen
Sara Graziadio
Stuart A. Taylor
Naomi S. Sakai
Kile Green
Jana Suklan
Chris Hyde
Bethany Shinkins
Zhivko Zhelev
Jaime Peters
Philip J. Turner
Nia W. Roberts
Lavinia Ferrante di Ruffano
Robert Wolff
Penny Whiting
Amanda Winter
Gauraang Bhatnagar
Brian D. Nicholson
Steve Halligan
At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant data
BMC Medicine
SARS-CoV-2
RT-PCR
COVID-19
QUADAS-2
Diagnostic test
Anatomical sampling
author_facet Sue Mallett
A. Joy Allen
Sara Graziadio
Stuart A. Taylor
Naomi S. Sakai
Kile Green
Jana Suklan
Chris Hyde
Bethany Shinkins
Zhivko Zhelev
Jaime Peters
Philip J. Turner
Nia W. Roberts
Lavinia Ferrante di Ruffano
Robert Wolff
Penny Whiting
Amanda Winter
Gauraang Bhatnagar
Brian D. Nicholson
Steve Halligan
author_sort Sue Mallett
title At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant data
title_short At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant data
title_full At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant data
title_fullStr At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant data
title_full_unstemmed At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant data
title_sort at what times during infection is sars-cov-2 detectable and no longer detectable using rt-pcr-based tests? a systematic review of individual participant data
publisher BMC
series BMC Medicine
issn 1741-7015
publishDate 2020-11-01
description Abstract Background Tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral ribonucleic acid (RNA) using reverse transcription polymerase chain reaction (RT-PCR) are pivotal to detecting current coronavirus disease (COVID-19) and duration of detectable virus indicating potential for infectivity. Methods We conducted an individual participant data (IPD) systematic review of longitudinal studies of RT-PCR test results in symptomatic SARS-CoV-2. We searched PubMed, LitCOVID, medRxiv, and COVID-19 Living Evidence databases. We assessed risk of bias using a QUADAS-2 adaptation. Outcomes were the percentage of positive test results by time and the duration of detectable virus, by anatomical sampling sites. Results Of 5078 studies screened, we included 32 studies with 1023 SARS-CoV-2 infected participants and 1619 test results, from − 6 to 66 days post-symptom onset and hospitalisation. The highest percentage virus detection was from nasopharyngeal sampling between 0 and 4 days post-symptom onset at 89% (95% confidence interval (CI) 83 to 93) dropping to 54% (95% CI 47 to 61) after 10 to 14 days. On average, duration of detectable virus was longer with lower respiratory tract (LRT) sampling than upper respiratory tract (URT). Duration of faecal and respiratory tract virus detection varied greatly within individual participants. In some participants, virus was still detectable at 46 days post-symptom onset. Conclusions RT-PCR misses detection of people with SARS-CoV-2 infection; early sampling minimises false negative diagnoses. Beyond 10 days post-symptom onset, lower RT or faecal testing may be preferred sampling sites. The included studies are open to substantial risk of bias, so the positivity rates are probably overestimated.
topic SARS-CoV-2
RT-PCR
COVID-19
QUADAS-2
Diagnostic test
Anatomical sampling
url http://link.springer.com/article/10.1186/s12916-020-01810-8
work_keys_str_mv AT suemallett atwhattimesduringinfectionissarscov2detectableandnolongerdetectableusingrtpcrbasedtestsasystematicreviewofindividualparticipantdata
AT ajoyallen atwhattimesduringinfectionissarscov2detectableandnolongerdetectableusingrtpcrbasedtestsasystematicreviewofindividualparticipantdata
AT saragraziadio atwhattimesduringinfectionissarscov2detectableandnolongerdetectableusingrtpcrbasedtestsasystematicreviewofindividualparticipantdata
AT stuartataylor atwhattimesduringinfectionissarscov2detectableandnolongerdetectableusingrtpcrbasedtestsasystematicreviewofindividualparticipantdata
AT naomissakai atwhattimesduringinfectionissarscov2detectableandnolongerdetectableusingrtpcrbasedtestsasystematicreviewofindividualparticipantdata
AT kilegreen atwhattimesduringinfectionissarscov2detectableandnolongerdetectableusingrtpcrbasedtestsasystematicreviewofindividualparticipantdata
AT janasuklan atwhattimesduringinfectionissarscov2detectableandnolongerdetectableusingrtpcrbasedtestsasystematicreviewofindividualparticipantdata
AT chrishyde atwhattimesduringinfectionissarscov2detectableandnolongerdetectableusingrtpcrbasedtestsasystematicreviewofindividualparticipantdata
AT bethanyshinkins atwhattimesduringinfectionissarscov2detectableandnolongerdetectableusingrtpcrbasedtestsasystematicreviewofindividualparticipantdata
AT zhivkozhelev atwhattimesduringinfectionissarscov2detectableandnolongerdetectableusingrtpcrbasedtestsasystematicreviewofindividualparticipantdata
AT jaimepeters atwhattimesduringinfectionissarscov2detectableandnolongerdetectableusingrtpcrbasedtestsasystematicreviewofindividualparticipantdata
AT philipjturner atwhattimesduringinfectionissarscov2detectableandnolongerdetectableusingrtpcrbasedtestsasystematicreviewofindividualparticipantdata
AT niawroberts atwhattimesduringinfectionissarscov2detectableandnolongerdetectableusingrtpcrbasedtestsasystematicreviewofindividualparticipantdata
AT laviniaferrantediruffano atwhattimesduringinfectionissarscov2detectableandnolongerdetectableusingrtpcrbasedtestsasystematicreviewofindividualparticipantdata
AT robertwolff atwhattimesduringinfectionissarscov2detectableandnolongerdetectableusingrtpcrbasedtestsasystematicreviewofindividualparticipantdata
AT pennywhiting atwhattimesduringinfectionissarscov2detectableandnolongerdetectableusingrtpcrbasedtestsasystematicreviewofindividualparticipantdata
AT amandawinter atwhattimesduringinfectionissarscov2detectableandnolongerdetectableusingrtpcrbasedtestsasystematicreviewofindividualparticipantdata
AT gauraangbhatnagar atwhattimesduringinfectionissarscov2detectableandnolongerdetectableusingrtpcrbasedtestsasystematicreviewofindividualparticipantdata
AT briandnicholson atwhattimesduringinfectionissarscov2detectableandnolongerdetectableusingrtpcrbasedtestsasystematicreviewofindividualparticipantdata
AT stevehalligan atwhattimesduringinfectionissarscov2detectableandnolongerdetectableusingrtpcrbasedtestsasystematicreviewofindividualparticipantdata
_version_ 1724433123504029696